Helicase Regulation of dsRNA Signaling and Innate Antiviral Immune Responses

dsRNA 信号传导和先天抗病毒免疫反应的解旋酶调节

基本信息

  • 批准号:
    7994748
  • 负责人:
  • 金额:
    $ 37.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-12-15 至 2012-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long term objective for this project is to understand the regulatory mechanisms and specific mediators of innate antiviral responses. A major contribution to host immune responses to virus infection is the production of and response to type I interferon (IFN). Virus infection or accumulated virus replication intermediates like double-stranded RNA (dsRNA) can trigger IFN biosynthesis in most cells irrespective of the presence of Toll-like receptor systems. Detection of cytosolic dsRNA is mediated by a family of sensor proteins that includes RIG-I, MDA5, and LGP2, three proteins that contain DEXD/H-box RNA helicase domains. RIG-I and MDA5 helicase domains are fused to an N-terminal region homologous to CARD domain proteins, and are positive signaling proteins leading to IFN biosynthesis. LGP2 lacks the CARD domain, and has been characterized as a feedback inhibitor for IFN synthesis. Despite the RNA helicase domain similarities, little is known about the specific enzymatic activities and how catalytic activity can influence the signaling. Preliminary results and published reports reveal a high degree of specificity in RNA recognition and differential requirements for enzymatic activity among the helicase proteins. Further specificity is revealed by natural inhibitors, paramyxovirus V proteins, that selectively target MDA5 and LGP2, but not RIG-I. This proposal will determine RNA target preferences and roles for enzymatic specialization that confer specificity and selectivity to helicase-mediated antiviral responses. The molecular basis for selective paramyxovirus helicase interference will be revealed and correlated with biological evaluation of the contributions of MDA5 and LGP2 to host responses. Regulatory mechanisms and cellular partners for helicase-mediated signaling will be characterized. These aims will expose specificity determinants for both positive and negative regulation of the intracellular innate antiviral response. Paramyxoviruses like measles, mumps human parainfluenza, and respiratory syncytial viruses, as well as other RNA viruses including influenza, HIV, Ebola and hepatitis C viruses are infectious threats to human health worldwide. The proposed experiments will reveal basic mechanisms of cellular antiviral responses and determine the molecular basis for both cellular and viral inhibition mechanisms. This strategy will reveal the strengths and vulnerabilities of the antiviral response and identify targets for therapeutic intervention.
描述(由申请人提供):该项目的长期目标是了解先天抗病毒反应的调节机制和特定媒介。对病毒感染的宿主免疫反应的一个主要贡献是I型干扰素的产生和反应。病毒感染或累积的病毒复制中间产物如双链RNA(DsRNA)可在大多数细胞中触发干扰素的生物合成,而与Toll样受体系统的存在无关。胞质dsRNA的检测是由一系列传感器蛋白介导的,其中包括RIG-I、MDA5和LGP2,这三种蛋白含有DEXD/H-box RNA解旋酶结构域。RIG-I和MDA5解旋酶结构域融合在一个与CARD结构域蛋白同源的N-末端,是导致干扰素生物合成的阳性信号蛋白。LGP2缺乏CARD结构域,被认为是干扰素合成的反馈抑制因子。尽管RNA解旋酶结构域相似,但人们对其特定的酶活性以及催化活性如何影响信号转导知之甚少。初步结果和已发表的报告显示,在RNA识别和不同解旋酶蛋白对酶活性的不同要求方面具有高度的特异性。天然的抑制物,副粘病毒V蛋白,选择性地针对MDA5和LGP2,而不是RIG-I,揭示了进一步的特异性。这项提议将确定RNA靶标偏好和酶特化的作用,赋予解旋酶介导的抗病毒反应特异性和选择性。选择性副粘病毒解旋酶干扰的分子基础将被揭示,并与MDA5和LGP2对宿主反应的贡献的生物学评估相关联。将描述解旋酶介导的信号的调节机制和细胞伙伴。这些目的将揭示细胞内固有抗病毒反应的积极和消极调节的特异性决定因素。副粘病毒如麻疹、腮腺炎、人类副流感和呼吸道合胞病毒,以及其他RNA病毒包括流感、艾滋病毒、埃博拉病毒和丙型肝炎病毒,在全球范围内都是对人类健康的传染性威胁。拟议的实验将揭示细胞抗病毒反应的基本机制,并确定细胞和病毒抑制机制的分子基础。这一战略将揭示抗病毒反应的优势和弱点,并确定治疗干预的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CURT M HORVATH其他文献

CURT M HORVATH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CURT M HORVATH', 18)}}的其他基金

A robotic plate handling system for high content screening and 3D organoid culture
用于高内涵筛选和 3D 类器官培养的机器人板处理系统
  • 批准号:
    10431246
  • 财政年份:
    2022
  • 资助金额:
    $ 37.81万
  • 项目类别:
Mechanisms and Modifiers of Zika Virus Innate Immune Evasion
寨卡病毒先天免疫逃避的机制和修饰因素
  • 批准号:
    10056954
  • 财政年份:
    2020
  • 资助金额:
    $ 37.81万
  • 项目类别:
Analysis of Novel Virus-Induced RNAs
新型病毒诱导的 RNA 分析
  • 批准号:
    9321119
  • 财政年份:
    2015
  • 资助金额:
    $ 37.81万
  • 项目类别:
Analysis of Novel Virus-Induced RNAs
新型病毒诱导的 RNA 分析
  • 批准号:
    9118309
  • 财政年份:
    2015
  • 资助金额:
    $ 37.81万
  • 项目类别:
New Paradigms in Gene Regulation During Influenza Virus Infections
流感病毒感染期间基因调控的新范式
  • 批准号:
    8064308
  • 财政年份:
    2009
  • 资助金额:
    $ 37.81万
  • 项目类别:
New Paradigms in Gene Regulation During Influenza Virus Infections
流感病毒感染期间基因调控的新范式
  • 批准号:
    7779440
  • 财政年份:
    2009
  • 资助金额:
    $ 37.81万
  • 项目类别:
New Paradigms in Gene Regulation During Influenza Virus Infections
流感病毒感染期间基因调控的新范式
  • 批准号:
    8508068
  • 财政年份:
    2009
  • 资助金额:
    $ 37.81万
  • 项目类别:
New Paradigms in Gene Regulation During Influenza Virus Infections
流感病毒感染期间基因调控的新范式
  • 批准号:
    8261138
  • 财政年份:
    2009
  • 资助金额:
    $ 37.81万
  • 项目类别:
New Paradigms in Gene Regulation During Influenza Virus Infections
流感病毒感染期间基因调控的新范式
  • 批准号:
    7907073
  • 财政年份:
    2009
  • 资助金额:
    $ 37.81万
  • 项目类别:
Helicase Regulation of dsRNA Signaling and Innate Antiviral Immune Responses
dsRNA 信号传导和先天抗病毒免疫反应的解旋酶调节
  • 批准号:
    8197223
  • 财政年份:
    2007
  • 资助金额:
    $ 37.81万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.81万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了